A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors

NCT05036291 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Development change

Conditions

Advanced Solid Tumor

Interventions

DRUG: NB004 tablets

Sponsor

Ningbo Newbay Technology Development Co., Ltd